Also, the therapeutic approaches are getting better. A new paper describes the markers in the blood that can guide the choice of what treatment is going to work for a particular patient. And there are a fair number of mini-antibodies (aka nanobodies) being developed that should do the same job that the monoclonal antibodies did for Trump but at a much lower cost and with greater possibility for rapid production. Scienc is there for us, but it takes time and effort. Hang in there everybody!
Also, the therapeutic approaches are getting better. A new paper describes the markers in the blood that can guide the choice of what treatment is going to work for a particular patient. And there are a fair number of mini-antibodies (aka nanobodies) being developed that should do the same job that the monoclonal antibodies did for Trump but at a much lower cost and with greater possibility for rapid production. Scienc is there for us, but it takes time and effort. Hang in there everybody!